Stocks pricing in the least growth: Healthcare
A reverse DCF asks what yearly free cash flow growth today's price assumes (10 years at a 9% discount rate, 3% after). Healthcare companies worth over $1 billion with the lowest answer: the market expects the least. One unusually strong year of cash flow can also land a company here, so check its history.
Top of the list: Bausch Health Companies (BHC) -27.0%; Teladoc (TDOC) -11.8%; Harmony Biosciences Holdings (HRMY) -9.8%.
The median growth priced in across these 50 companies is +0.2%.
| # | Company | Growth priced in | FCF growth delivered | P/FCF | P/E | Market cap |
|---|---|---|---|---|---|---|
| 1 | Bausch Health Companies IncBHC | -27.0% | -6.6% | 2.31x | 15.4x | $2.3B |
| 2 | Teladoc IncTDOC | -11.8% | +36.0% | 3.53x | — | $1.0B |
| 3 | Harmony Biosciences HoldingsHRMY | -9.8% | +37.2% | 6.82x | 16.5x | $2.4B |
| 4 | Organon & CoOGN | -9.5% | -24.6% | 6.80x | 15.0x | $3.7B |
| 5 | Pacira BioSciences, Inc.PCRX | -8.3% | +35.7% | 10.7x | 284.6x | $1.5B |
| 6 | Innoviva IncINVA | -7.9% | +13.9% | 7.68x | 3.26x | $1.5B |
| 7 | Prestige Brand Holdings IncPBH | -6.4% | +6.0% | 8.32x | 11.4x | $2.1B |
| 8 | Tenet Healthcare CorporationTHC | -6.2% | +22.7% | 8.65x | 13.2x | $21.9B |
| 9 | DaVita HealthCare Partners IncDVA | -6.1% | +1.5% | 8.80x | 17.3x | $11.5B |
| 10 | Surgery Partners IncSGRY | -6.0% | +14.4% | 8.88x | — | $1.7B |
| 11 | CONMED CorporationCNMD | -5.9% | +22.0% | 8.81x | 29.3x | $1.3B |
| 12 | Amphastar PAMPH | -5.7% | +24.2% | 8.92x | 14.8x | $1.1B |
| 13 | ANI Pharmaceuticals IncANIP | -5.3% | +25.1% | 9.46x | 18.2x | $1.6B |
| 14 | Bristol-Myers Squibb CompanyBMY | -4.7% | +24.1% | 9.50x | 16.7x | $122.0B |
| 15 | Oscar Health IncOSCR | -4.5% | +38.4% | 9.86x | — | $10.4B |
| 16 | Viatris IncVTRS | -4.5% | -1.1% | 9.79x | — | $19.0B |
| 17 | Healthcare Services Group IncHCSG | -4.3% | +16.2% | 9.84x | 21.0x | $1.4B |
| 18 | HCA Holdings IncHCA | -1.7% | +11.5% | 12.3x | 14.7x | $94.7B |
| 19 | Zimmer Biomet Holdings IncZBH | -1.6% | +0.2% | 12.2x | 24.0x | $17.9B |
| 20 | Universal Health Services IncUHS | -1.6% | +0.5% | 12.3x | 7.21x | $10.4B |
| 21 | Progyny IncPGNY | -1.4% | +96.5% | 12.3x | 29.9x | $2.4B |
| 22 | Cardinal Health IncCAH | -1.1% | +21.3% | 31.5x | 32.9x | $58.3B |
| 23 | Doximity IncDOCS | -0.3% | +56.1% | 14.3x | 25.2x | $4.7B |
| 24 | Alkermes PlcALKS | -0.1% | +48.7% | 13.6x | 43.5x | $6.5B |
| 25 | Smith & Nephew SNATS IncSNN | +0.2% | +7.2% | 14.0x | 37.8x | $12.0B |
| 26 | Zoetis IncZTS | +0.3% | +18.5% | 14.6x | 13.0x | $33.3B |
| 27 | CVS Health CorpCVS | +0.4% | -0.2% | 14.0x | 37.7x | $109.7B |
| 28 | Perrigo Company PLCPRGO | +0.5% | -13.7% | 14.7x | — | $2.1B |
| 29 | Biomarin Pharmaceutical IncBMRN | +0.5% | +36.5% | 14.1x | 38.1x | $10.2B |
| 30 | ICON PLCICLR | +0.6% | +16.6% | 11.0x | 21.4x | $12.4B |
| 31 | Biogen IncBIIB | +1.1% | -7.1% | 14.8x | 22.2x | $30.4B |
| 32 | Dentsply Sirona IncXRAY | +1.7% | -14.8% | 16.0x | — | $1.7B |
| 33 | Envista Holdings CorpNVST | +1.8% | -3.6% | 15.7x | 54.1x | $3.6B |
| 34 | Exelixis IncEXEL | +2.0% | +17.5% | 16.9x | 18.8x | $14.3B |
| 35 | Astrana Health IncASTH | +2.4% | +9.7% | 17.2x | 59.2x | $1.8B |
| 36 | Regeneron Pharmaceuticals IncREGN | +2.6% | +17.2% | 16.8x | 16.0x | $68.5B |
| 37 | Boston Scientific CorpBSX | +2.7% | +18.3% | 17.2x | 17.8x | $63.1B |
| 38 | Waystar Holding Corp. Common StockWAY | +3.1% | +49.2% | 17.9x | 39.5x | $5.1B |
| 39 | Pfizer IncPFE | +3.2% | -5.0% | 17.5x | 21.3x | $159.3B |
| 40 | Henry Schein IncHSIC | +3.2% | +0.0% | 17.5x | 26.6x | $10.0B |
| 41 | Lantheus Holdings IncLNTH | +3.4% | +26.6% | 17.7x | 23.0x | $6.3B |
| 42 | Globus MedicalGMED | +3.6% | +20.9% | 18.2x | 18.4x | $10.7B |
| 43 | Novartis AG ADRNVS | +3.6% | +6.6% | 15.6x | 20.1x | $275.6B |
| 44 | Quest Diagnostics IncorporatedDGX | +3.7% | +5.7% | 18.4x | 25.0x | $25.0B |
| 45 | Certara IncCERT | +4.1% | +16.1% | 14.0x | — | $1.3B |
| 46 | Becton Dickinson and CompanyBDX | +4.2% | +4.2% | 18.9x | 32.0x | $50.4B |
| 47 | Neurocrine Biosciences IncNBIX | +4.2% | +38.5% | 18.6x | 21.4x | $14.0B |
| 48 | Omnicell IncOMCL | +4.3% | +10.1% | 19.2x | 83.5x | $1.7B |
| 49 | Gilead Sciences IncGILD | +4.3% | -5.9% | 19.5x | 20.2x | $184.1B |
| 50 | Haemonetics CorporationHAE | +4.3% | +13.1% | 21.6x | 60.5x | $5.6B |
Ranked from each company's latest price and reported results. Companies need a page on Investingly (SEC statements on file). Open any company for its reverse DCF, insider buying and 13F holders.
Other sectors
Questions
Which company ranks first on the stocks pricing in the least growth: healthcare list?
Bausch Health Companies (BHC), with a growth priced in of -27.0%, as of October 12, 2026.
How is this list built?
A reverse DCF asks what yearly free cash flow growth today's price assumes (10 years at a 9% discount rate, 3% after). US companies worth over $1 billion with the lowest answer: the market expects the least. One unusually strong year of cash flow can also land a company here, so check its history. It shows the top 50 and is rebuilt every day.
Prices and ratios as of Oct 11, 2026. Statements from SEC filings. Information only, not investment advice.